Hematology and Oncology

Odds of VTE increased 8.15-fold according to models adjusting for recent hospitalization and steroid exposure

Decrease in life expectancy larger than that seen in other high-income countries; pronounced decreases seen for Hispanic, non-Hispanic Black populations

Seventy-five percent of patients achieved a best response of bone marrow-undetectable measurable residual disease remission

Prophylactic-dose anticoagulation, but not treatment-dose anticoagulation, associated with lower 60-day mortality

Surge in enrollment during pandemic means that a quarter of the U.S. population is now covered by the public program

Findings seen in a large study of veterans undergoing diagnostic colonoscopy

AAD survey revealed that 49 percent of respondents were more worried about avoiding sunburn than preventing skin cancer

Pradaxa approved for children ages 3 months to 12 years with VTE directly after treatment with injectable blood thinner for at least five days

Lower 30-day mortality seen in hospitalized adults, including those admitted to ICU, requiring mechanical ventilation

Complete response rate improved compared with conventional external beam radiotherapy